Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven P Marso

Showing results (41-50 of 143) with videos related to

Pageof 15
Sort By:
European Heart Journal|May 8, 2007
Intravascular ultrasound radiofrequency analysis of coronary atherosclerosis: an emerging technology for the assessment of vulnerable plaqueSameer K Mehta, Justin R McCrary, Andrew D Frutkin, et al.
JACC. Cardiovascular Interventions|February 14, 2012
Percutaneous coronary intervention use in the United States: defining measures of appropriatenessSteven P Marso, Paul S Teirstein, Dean J Kereiakes, et al.
JACC. Cardiovascular Interventions|June 23, 2009
Chronic total occlusion angioplasty in the United StatesJ Aaron Grantham, Steven P Marso, John Spertus, et al.
The American Journal of Cardiology|September 17, 2002
Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitusDeepak L Bhatt, Steven P Marso, Alan T Hirsch, et al.
Diabetes Care|July 29, 2006
Suspected acute coronary syndrome patients with diabetes and normal troponin-I levels are at risk for early and late death: Identification of a new high-risk acute coronary syndrome populationSteven P Marso, David M Safley, John A House, et al.
Diabetes Care|February 7, 2008
Low adiponectin levels are associated with atherogenic dyslipidemia and lipid-rich plaque in nondiabetic coronary arteriesSteven P Marso, Sameer K Mehta, Andrew Frutkin, et al.
The American Journal of Cardiology|April 9, 2018
Myocardial Infarction Subtypes in Patients With Type 2 Diabetes Mellitus and the Effect of Liraglutide Therapy (from the LEADER Trial)Steven P Marso, Michael A Nauck, Tea Monk Fries, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 20, 2016
Association between health status and long-term mortality after percutaneous revascularization of peripheral artery diseaseMatthew C Bunte, John A House, John A Spertus, et al.
American Heart Journal|November 19, 2011
Mode of death after contemporary percutaneous coronary intervention: a report from the Evaluation of Drug Eluting Stents and Ischemic Events registryJoshua M Stolker, David J Cohen, Jason B Lindsey, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 29, 2012
Management of hyperglycemia with the administration of intravenous exenatide to patients in the cardiac intensive care unitMohammad Abuannadi, Mikhail Kosiborod, Lisa Riggs, et al.
Pageof 15

Showing results (41-50 of 143) with videos related to

Sort By:
Pageof 15
European Heart Journal|May 8, 2007
Intravascular ultrasound radiofrequency analysis of coronary atherosclerosis: an emerging technology for the assessment of vulnerable plaqueSameer K Mehta, Justin R McCrary, Andrew D Frutkin, et al.
JACC. Cardiovascular Interventions|February 14, 2012
Percutaneous coronary intervention use in the United States: defining measures of appropriatenessSteven P Marso, Paul S Teirstein, Dean J Kereiakes, et al.
JACC. Cardiovascular Interventions|June 23, 2009
Chronic total occlusion angioplasty in the United StatesJ Aaron Grantham, Steven P Marso, John Spertus, et al.
The American Journal of Cardiology|September 17, 2002
Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitusDeepak L Bhatt, Steven P Marso, Alan T Hirsch, et al.
Diabetes Care|July 29, 2006
Suspected acute coronary syndrome patients with diabetes and normal troponin-I levels are at risk for early and late death: Identification of a new high-risk acute coronary syndrome populationSteven P Marso, David M Safley, John A House, et al.
Diabetes Care|February 7, 2008
Low adiponectin levels are associated with atherogenic dyslipidemia and lipid-rich plaque in nondiabetic coronary arteriesSteven P Marso, Sameer K Mehta, Andrew Frutkin, et al.
The American Journal of Cardiology|April 9, 2018
Myocardial Infarction Subtypes in Patients With Type 2 Diabetes Mellitus and the Effect of Liraglutide Therapy (from the LEADER Trial)Steven P Marso, Michael A Nauck, Tea Monk Fries, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 20, 2016
Association between health status and long-term mortality after percutaneous revascularization of peripheral artery diseaseMatthew C Bunte, John A House, John A Spertus, et al.
American Heart Journal|November 19, 2011
Mode of death after contemporary percutaneous coronary intervention: a report from the Evaluation of Drug Eluting Stents and Ischemic Events registryJoshua M Stolker, David J Cohen, Jason B Lindsey, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 29, 2012
Management of hyperglycemia with the administration of intravenous exenatide to patients in the cardiac intensive care unitMohammad Abuannadi, Mikhail Kosiborod, Lisa Riggs, et al.
Pageof 15